Provided by Tiger Trade Technology Pte. Ltd.

Merit Medical

85.57
-0.5700-0.66%
Post-market: 85.570.00000.00%19:30 EDT
Volume:319.37K
Turnover:27.37M
Market Cap:5.10B
PE:35.20
High:86.50
Open:86.40
Low:85.23
Close:86.14
52wk High:94.75
52wk Low:59.74
Shares:59.65M
Float Shares:58.12M
Volume Ratio:0.65
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.43
EPS(LYR):2.13
ROE:9.19%
ROA:4.92%
PB:3.04
PE(LYR):40.17

Loading ...

BUZZ-Merit Medical rises as it buys cancer tissue marker maker View Point

Reuters
·
Apr 01

Merit Medical acquires View Point Medical for $140M

TIPRANKS
·
Apr 01

Merit Medical acquires View Point Medical for $140 million, adds OneMark breast localization system

Reuters
·
Apr 01

Merit Medical Acquires View Point Medical, Inc., Expanding the Merit Therapeutic Oncology Portfolio

THOMSON REUTERS
·
Apr 01

Merit Medical Systems Inc - Deal Valued at About $140 Mln With $90 Mln Paid at Closing

THOMSON REUTERS
·
Apr 01

Press Release: Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio

Dow Jones
·
Apr 01

Merit Medical Systems: Leveraging Medtronic Partnership to Enter High-Growth Interventional Pain Market

TIPRANKS
·
Mar 25

BRIEF-Medtronic And Merit Medical Systems Enter Into Agreement To Offer New, FDA-Cleared Viaverte System

Reuters
·
Mar 24

Medtronic signs distribution agreement with Merit Medical for ViaVerte basivertebral nerve ablation system

Reuters
·
Mar 24

Medtronic and Merit Medical Systems Enter Into Agreement to Offer New, FDA-Cleared Viaverte™ System, a Basivertebral Nerve Ablation Treatment for Chronic Vertebrogenic Lower-Back Pain

THOMSON REUTERS
·
Mar 24

A Look At Merit Medical Systems (MMSI) Valuation After The Recent Share Price Pullback

Simply Wall St.
·
Mar 22

Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Voyager Therapeutics (VYGR) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
Mar 17

Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent

GlobeNewswire
·
Mar 16